R. Wu
Q. Zhang
X. Luo
W. Yao
M. Zhou
Y. Wang
P. Ding
N. Zhang
S. Yang
P. Hilliard
K. Usuba
N.L. Young
A. Abad
Z. Chen
Y. Peng
J. Wu
K.H. Luke
V.S. Blanchette
X. Li
Capital Medical University, Beijing Children's Hospital, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Beijing, China
New Century Children's Hospital, Department of Hematology, Chengdu, China
Chengdu Women and Children Central Center Hospital, Hematology, Chengdu, China
Beijing Children's Hospital, Capital Medical University, Rehabilitation, Beijing, China
Beijing Children's Hospital, Capital Medical University, Rehabilitation, Beijing, China
The Hospital for Sick Children, Child Health Evaluative Sciences, Research Institute, Toronto, Canada
Laurentian University, School of Rural and Northern Health and the Research Centre for Evaluating Children's Health Outcomes (ECHO), Sudbury, Canada
Bayer Healthcare Co.Ltd, Medical Affairs, Beijing, China
Childrens Hospital of Eastern Ontario, University of Ottawa, Division of Hematology Pediatrics, Laboratory Medicine and Pathology, Ottawa, Canada
The Hospital for Sick Children, University of Toronto, Division of Hematology/Oncology; Department of Pediatrics, Toronto, Canada
China
Canada
N/A
Blood/haematological Diseases
Hemophilia
DNA Damage Inducible Transcript 3
FVIII
N/A
Prospective
Dose Escalation
NA
N/A
N/A
N/A